Artery Research
Volume 1, Issue 1 , Pages 32-38 , June 2007

Inflammation and arterial function

Received 22 September 2006 ,Revised 26 February 2007 ,Accepted 28 February 2007.

References 

  1. Vlachopoulos C, Aznaouridis K, Stefanadis C. Clinical appraisal of arterial stiffness: the Argonauts in front of the Golden Fleece. Heart. 2006;92:1544–1550
  2. Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J, et al. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the working group on endothelins and endothelial factors of the European society of hypertension. J Hypertens. 2005;23:233–246
  3. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–1241
  4. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension. 2001;38:434–438
  5. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113:1213–1225
  6. McEniery CM, Yasmin , Hall IR, Qasem A, Wilkinson IB, Cockcroft JR, et al. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity. The Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol. 2005;46:1753–1760
  7. Wojciechowska W, Staessen JA, Nawrot T, Cwynar M, Seidlerova J, Stolarz K, et al. Reference values in white Europeans for the arterial pulse wave recorded by means of the SphygmoCor device. Hypertens Res. 2006;29:475–483
  8. Hansson GK. Inflammation, Atherosclerosis, and Coronary Artery Disease. N Engl J Med. 2005;352:1685–1695
  9. Wakabayashi I, Masuda H. Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus. Clin Chim Acta. 2006;365:230–235
  10. Diamant M, Lamb HJ, van de Ree MA, Endert EL, Groeneveld Y, Bots ML, et al. The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes. J Clin Endocrinol Metab. 2005;90:1495–1501
  11. Ferreira I, Henry RM, Twisk JW, van Mechelen W, Kemper HC, Stehouwer CD. The metabolic syndrome, cardiopulmonary fitness, and subcutaneous trunk fat as independent determinants of arterial stiffness. The Amsterdam growth and health longitudinal study. Arch Intern Med. 2005;165:875–882
  12. Pirro M, Schillaci G, Savarese G, Gemelli F, Mannarino MR, Siepi D, et al. Low-grade systemic inflammation impairs arterial stiffness in newly diagnosed hypercholesterolaemia. Eur J Clin Invest. 2004;34:335–341
  13. Pietri P, Vyssoulis G, Vlachopoulos C, Zervoudaki A, Gialernios T, Aznaouridis K, et al. Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension. J Hypertens. 2006;24:2231–2238
  14. Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension. 2005;46:1118–1122
  15. Kampus P, Muda P, Kals J, Ristimae T, Fischer K, Teesalu R, et al. The relationship between inflammation and arterial stiffness in patients with essential hypertension. Int J Cardiol. 2006;112:46–51
  16. Mahmud A, Feely J. Adiponectin and arterial stiffness. Am J Hypertens. 2005;18:1543–1548
  17. Vlachopoulos C, Aznaouridis K, Vyssoulis G, Zervoudaki A, Pietri P, Kyvelou SM, et al. Large-artery stiffening is associated with increased fibrinogen level in hypertensive patients. World Congress of Cardiology. 2006;[abstract]
  18. Vlachopoulos C, Aznaouridis K, Ioakeimidis N, Rokkas K, Vasiliadou C, Alexopoulos N, et al. Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. Eur Heart J. 2006;22:2640–2648
  19. Vlachopoulos C, Ioakeimidis N, Tsekoura D, Aznaouridis K, Rokkas K, Alexopoulos N, et al. Aortic stiffness and carotid intima media thickness are associated with penile doppler findings in patients with vasculogenic erectile dysfunction. AHA Scientific Sessions. 2006;[abstract]
  20. Kullo IJ, Seward JB, Bailey KR, Bielak LF, Grossardt BR, Sheedy PF, et al. C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Am J Hypertens. 2005;18:1123–1129
  21. Yasmin , McEniery CM, Wallace S, Mackenzie IS, Cockcroft JR, Wilkinson IB. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol. 2004;24:969–974
  22. Vlachopoulos C, Aznaouridis K, Dima I, Ioakeimidis N, Vasiliadou C, Zervoudaki A, et al. Negative association between serum levels of matrix metalloproteinases-2 and -9 and aortic stiffness in healthy adults. Int J Cardiol. 2007 Feb 6;[Epub ahead of print]
  23. Yasmin , Wallace S, McEniery CM, Dakham Z, Pusalkar P, Maki-Petaja K, et al. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol. 2005;25:372–378
  24. Tronc F, Mallat Z, Lehoux S, Wassef M, Esposito B, Tedgui A. Role of matrix metalloproteinases in blood flow-induced arterial enlargement. Interaction with NO. Arterioscler Thromb Vasc Biol. 2000;20:e120–e126
  25. Vlachopoulos C, Aznaouridis K, Pietri P, Ioakeimidis N, Stefanadis C. White blood cell count is a marker of wave reflections and arterial stiffness in healthy individuals. Atherosclerosis. 2006;187:218–219
  26. Volanen I, Jarvisalo MJ, Vainionpaa R, Arffman M, Kallio K, Angle S, et al. Increased aortic intima-media thickness in 11-year-old healthy children with persistent Chlamydia pneumoniae seropositivity. Arterioscler Thromb Vasc Biol. 2006;26:649–655
  27. Roman MJ, Devereux RB, Schwartz JE, Lockshin MD, Paget SA, Davis A, et al. Arterial stiffness in chronic inflammatory diseases. Hypertension. 2005;46:194–199
  28. Klocke R, Cockcroft JR, Taylor GJ, Hall IR, Blake DR. Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann Rheum Dis. 2003;62:414–418
  29. Datta D, Ferrell WR, Sturrock RD, Jadhav ST, Sattar N. Inflammatory suppression rapidly attenuates microvascular dysfunction in rheumatoid arthritis. Atherosclerosis. 2006 Jun 22;[Epub ahead of print]
  30. Booth AD, Wallace S, McEniery CM, Yasmin , Brown J, Jayne DR, et al. Inflammation and arterial stiffness in systemic vasculitis. A model of vascular inflammation. Arthr Rheum. 2004;50:581–588
  31. Senzaki H, Chen C-H, Ishido H, Masutani S, Matsunaga T, Taketazu M, et al. Arterial hemodynamics in patients after Kawasaki disease. Circulation. 2005;111:2119–2125
  32. Charakida M, Donald AE, Green H, Clare Storry , Margaret Clapson , Caslake M, et al. Early structural and functional changes of the vasculature in HIV-infected children. Impact of disease and antiretroviral therapy. Circulation. 2005;112:103–109
  33. Protogerou A, Lekakis J, Stamatelopoulos K, Aznaouridis K, Karatzis E, Ikonomidis I, et al. Arterial wall characteristics in patients with Adamantiades-Behcet's disease. Adv Exp Med Biol. 2003;528:399–404
  34. Protogerou AD, Lekakis J, Ikonomidis I, Stamatelopoulos K, Aznaouridis K, KaratziS EN, et al. Pressure wave reflections, central blood pressure, and aortic stiffness in patients with Adamantiades-Behcet’s disease. A cross-sectional case-control study underlining the role of chronic corticosteroid treatment. Am J Hypertens. 2006;19:660–666
  35. Ikonomidis I, Aznaouridis K, Protogerou A, Stamatelopoulos K, Markomihelakis N, Papamichael C, et al. Arterial wave reflections are associated with left ventricular diastolic dysfunction in Adamantiades-Behcet's disease. J Card Fail. 2006;12:458–463
  36. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351:2611–2618
  37. Charakida M, Donald AE, Terese M, Leary S, Halcox JP, Ness A, et al. for the ALSPAC (Avon Longitudinal Study of Parents and Children) Study Team. Endothelial dysfunction in childhood infection. Circulation. 2005;111:1660–1665
  38. Hingorani AD, Cross J, Kharbanda RK, Mullen M, Bhagat K, Taylor M, et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation. 2000;102:994–999
  39. Kharbanda RK, Walton B, Allen M, Klein N, Hingorani AD, MacAllister RJ, et al. Prevention of inflammation-induced endothelial dysfunction. A novel vasculo-protective action of aspirin. Circulation. 2002;105:2600–2604
  40. Clapp BR, Hirschfield GM, Storry C, Gallimore JR, Stidwill RP, Singer M, et al. Inflammation and endothelial function. Direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation. 2005;111:1530–1536
  41. Vlachopoulos C, Dima I, Aznaouridis K, Vasiliadou C, Ioakeimidis N, Aggeli C, et al. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation. 2005;112:2193–2200
  42. Wilkinson IB, Franklin SS, Cockcroft JR. Nitric oxide and the regulation of large artery stiffness. From physiology to pharmacology. Hypertension. 2004;44:112–116
  43. McNulty M, Mahmud A, Spiers P, Feely J. Collagen type-I degradation is related to arterial stiffness in hypertensive and normotensive subjects. J Hum Hypertens. 2006;20:867–873
  44. Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, et al. A self-fulfilling prophecy. C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002;106:913–919
  45. Taylor KE, Giddings JC, van den Berg CW. C-reactive protein–induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide. Arterioscler Thromb Vasc Biol. 2005;25:1225–1230
  46. Pepys MB, Hirschfield GM, Tennent GA, Gallimore JR, Kahan MC, Bellotti V, et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature. 2006;440:1217–1221
  47. Chenevard R, Hürlimann D, Béchir M, Enseleit F, Spieker L, Hermann M, et al. Selective COX-2 inhibition improves endothelial function in coronary artery disease. Circulation. 2003;107:405–409
  48. Vlachopoulos C, Bratsas A, Aznaouridis K, Ioakeimidis N, Vasiliadou C, Tousoulis D, et al. Celecoxib, a selective cyclooxygenase-2 inhibitor prevents the inflammatory activation acutely induced by smoking. World Congress of Cardiology. 2006;[abstract]
  49. Vlachopoulos C, Bratsas A, Aznaouridis K, Ioakeimidis N, Xaplanteris P, Alexopoulos N, et al. Selective cyclooxygenase-2 inhibition by celecoxib abrogates the acute smoking-induced vascular dysfunction. J Am Coll Cardiol. 2006;47(Suppl. 1):356A [abstract]
  50. Van Doornum S, McColl G, Wicks IP. Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis. Rheumatology (Oxford). 2005;44:1428–1432
  51. Maki-Petaja KM, Hall FC, Booth AD, Wallace SM, Yasmin , Bearcroft PW, et al. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-α therapy. Circulation. 2006;114:1185–1192
  52. Booth AD, Jayne DRQ, Kharbanda RK, McEniery CM, Mackenzie IS, Brown J, et al. Infliximab improves endothelial dysfunction in systemic vasculitis. A model of vascular inflammation. Circulation. 2004;109:1718–1723
  53. Van Doornum S, McColl G, Wicks IP. Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis. Ann Rheum Dis. 2004;63:1571–1575
  54. Tousoulis D, Antoniades C, Bosinakou E, Kotsopoulou M, Pitsavos C, Vlachopoulos C, et al. Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure. Atherosclerosis. 2005;178:359–363
  55. Aznaouridis K, Vlachopoulos C, Dagre A, Masoura C, Vasiliadou C, Dima I, et al. Atorvastatin abrogates the deterioration of endothelial function induced by acute inflammation in dyslipidemic patients. J Am Coll Cardiol. 2007;49(Suppl. 1):381A;[abstract]

☆ Disclosure of interest: There is no conflict of interest.Source of funding: None.

PII: S1872-9312(07)00006-3

doi: 10.1016/j.artres.2007.03.005

Artery Research
Volume 1, Issue 1 , Pages 32-38 , June 2007

Article Tools

* Image Usage & Resolution